Occlutech US LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$143Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
13clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2024 $117K
2025 $27K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Cardiovascular Disease $92K
Interventional Cardiology $36K
Neurology (Psychiatry & Neurology) $12K
Pediatric Cardiology $3,000
Hematology & Oncology $1,400

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Muthiah Vaduganathan Boston, MA Cardiovascular Disease $54,000.00
Gregg Stone New York, NY Cardiovascular Disease $28,875.00
Gareth Morgan Aurora, CO Interventional Cardiology $14,159.02
Steven Yakubov Columbus, OH Interventional Cardiology $12,000.00
Jay Simonson St Louis Park, MN Cardiovascular Disease $8,875.00
Jenny Zablah Alabi Aurora, CO Interventional Cardiology $6,900.38
Tanya Turan Charleston, SC Neurology (Psychiatry & Neurology) $5,693.40
Carlos Kase Boston, MA Neurology (Psychiatry & Neurology) $4,815.00
Daisuke Kobayashi Saint Louis, MO Pediatric Cardiology $3,000.00
Zahid Amin Orlando, FL Interventional Cardiology $2,250.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.